About the Journal
Aims and scope
Shanghai Chest (ISSN 2521-3768; Shanghai Chest; SHC; shc.amegroups.com) is an international peer-reviewed, open-access journal covering various aspects of benign and malignant chest diseases, including but not limited to: pulmonary diseases, tracheal and bronchial disorder, pleural diseases, esophageal disorder, mediastinal and chest wall diseases. As the Official Journal of Shanghai Chest Hospital, it not only presents the high-quality research and unique techniques from the Hospital, but also welcomes submissions from authors worldwide, publishing articles that focus on chest diseases in a wide ranges of forms and meet the professional and educational needs of its readers. SHC aims at serving as an international platform for surgeons and physicians worldwide to share the advanced research, spectacular surgical techniques and precious experience in the field of chest disease, for the ultimate benefit of all patients.
Published articles include Invited Articles and Submitted Papers, e-Comments on all published articles, and Editorials. In-depth research, instructional and educational video clips, photos, schematics will be a favor. Besides regular issues of the journal, articles in defined areas will be collected and published in Themed Collections. The high quality of its content is assured by a rigorous review process, supervised by a strong editorial board.
The entire submission and review process are mainly managed through OJS system, an electronic system, which provides an efficient way and ensures a rapid turnaround of papers submitted for publication. Articles will be published both in print and online. See more at Information for Authors.
Submission Turnaround Time:
Submission to First Editorial Decision: 2-4 weeks.
External Peer Review: 1-2 months.
Acceptance to Publication: 2-4 weeks. Original Articles are listed as priority.
AME Publishing Company:
Address: Rm C, 16/F, Kings Wing Plaza 1, No. 3 On Kwan Street, Shatin, NT, Hong Kong
Phone: +86 20 66355775
Updated date: September 18, 2019.